We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+25.8%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$290M
Cap. Flow
+$53.6M
Cap. Flow %
4.15%
Top 10 Hldgs %
55.08%
Holding
1,109
New
59
Increased
171
Reduced
182
Closed
40

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13.2M
2
MSFT icon
Microsoft
MSFT
+$12.7M
3
V icon
Visa
V
+$7.78M
4
MA icon
Mastercard
MA
+$4.67M
5
AMAT icon
Applied Materials
AMAT
+$4.67M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$16M
2
IDXX icon
Idexx Laboratories
IDXX
+$2.62M
3
ADBE icon
Adobe
ADBE
+$2M
4
MCD icon
McDonald's
MCD
+$1.75M
5
INTU icon
Intuit
INTU
+$1.63M

Sector Composition

Rank Sector Weight
1 Technology 24.35%
2 Financials 22.24%
3 Consumer Discretionary 18.99%
4 Communication Services 11.15%
5 Healthcare 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JKHY icon
426
Jack Henry & Associates
JKHY
$12.1B
$55.2K ﹤0.01%
300
ROP icon
427
Roper Technologies
ROP
$42.2B
$55.1K ﹤0.01%
142
TCPC icon
428
BlackRock TCP Capital
TCPC
$346M
$54.8K ﹤0.01%
6,000
EWY icon
429
iShares MSCI South Korea ETF
EWY
$28B
$54.3K ﹤0.01%
950
SCHW
430
Charles Schwab
SCHW
$191B
$54.2K ﹤0.01%
1,605
-260
-14% -$9.31K
CHWY icon
431
Chewy
CHWY
$9.52B
$53.6K ﹤0.01%
1,200
AKAM icon
432
Akamai
AKAM
$15.4B
$53.5K ﹤0.01%
500
+200
+67% +$20.1K
ALXN
433
DELISTED
Alexion Pharmaceuticals
ALXN
$53.3K ﹤0.01%
+475
New +$50.4K
PDD icon
434
Pinduoduo
PDD
$122B
$53.2K ﹤0.01%
620
-70
-10% -$4.21K
VEA icon
435
Vanguard FTSE Developed Markets ETF
VEA
$238B
$52.8K ﹤0.01%
1,360
ALGN icon
436
Align Technology
ALGN
$11.2B
$52.7K ﹤0.01%
192
-286
-60% -$64.4K
GCO icon
437
Genesco
GCO
$370M
$52K ﹤0.01%
2,400
XLNX
438
DELISTED
Xilinx Inc
XLNX
$52K ﹤0.01%
528
+278
+111% +$24.7K
STAA icon
439
STAAR Surgical
STAA
$1.11B
$50.8K ﹤0.01%
825
VNQI icon
440
Vanguard Global ex-US Real Estate ETF
VNQI
$3.49B
$50.7K ﹤0.01%
1,086
INVX
441
Innovex International
INVX
$2.11B
$50.2K ﹤0.01%
1,685
AIMT
442
DELISTED
Aimmune Therapeutics
AIMT
$50.1K ﹤0.01%
+3,000
New +$50.9K
ROL icon
443
Rollins
ROL
$17.5B
$50K ﹤0.01%
1,770
INGR icon
444
Ingredion
INGR
$6.6B
$49.6K ﹤0.01%
598
RSG icon
445
Republic Services
RSG
$68B
$49.2K ﹤0.01%
600
SU icon
446
Suncor Energy
SU
$76.5B
$49.2K ﹤0.01%
2,919
USB icon
447
US Bancorp
USB
$97.3B
$48.8K ﹤0.01%
1,325
+25
+2% +$891
SOXX icon
448
iShares Semiconductor ETF
SOXX
$41.5B
$48.8K ﹤0.01%
540
ELV icon
449
Elevance Health
ELV
$85.5B
$48.7K ﹤0.01%
185
EMB icon
450
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$48.3K ﹤0.01%
442

Similar funds

RBC Europe's Q2 2020 Portfolio in Review

As of Q2 2020, RBC Europe held 1,109 positions worth $1.29B, up 29% from $1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

RBC Europe deployed $53.6M of net new capital in Q2 2020, opening 59 new positions and adding to 171 existing holdings. Its largest new stake was S&P Global: 6,016 shares worth $1.98M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $16M trimmed.

  • RBC Europe's largest Q2 2020 buy was S&P Global: 6,016 shares worth $1.98M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2020, an estimated $13.2M increase.
  • RBC Europe's biggest Q2 2020 reduction was Tesla, cutting an estimated $16M.
  • RBC Europe fully exited Raytheon Company in Q2 2020, selling an estimated $558K.
  • RBC Europe's ten largest holdings make up 55% of its $1.29B portfolio in Q2 2020.
  • RBC Europe opened 59 new positions and closed 40 in Q2 2020.
  • RBC Europe's portfolio value rose 29% quarter-over-quarter to $1.29B.

Based on RBC Europe's 13F filing for Q2 2020, filed 9 Nov 2023.